Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Kiraz

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Annals of Internal Medicine|March 15, 1997
Treatment of Beçhet disease with pentoxifyllineM Arici, S Kiraz, I Ertenli
Clinical Nephrology|January 1, 1996
Increased prothrombin fragment 1.2 concentrations in hemodialysis patientsY Erdem, I C Haznedaroğlu, S Kiraz
Clinical and Experimental Rheumatology|January 1, 1996
Parvovirus B19 infection in Behçet's diseaseS Kiraz, I Ertenli, M Benekli, et al.
Annals of the Rheumatic Diseases|August 3, 2001
Parvovirus B19 infection in Behçet's diseaseS Kiraz, M A Oztürk, I Ertenli, et al.
Clinical Rheumatology|September 1, 1996
Antineutrophil cytoplasmic antibodies in systemic sclerosisS Kiraz, H Simsek, I Ertenli, et al.
Clinical and Experimental Rheumatology|April 22, 2010
Endothelial nitric oxide gene polymorphism and risk of systemic sclerosis: predisposition effect of T-786C promoter and protective effect of 27 bp repeats in Intron 4I Sinici, U Kalyoncu, S Karahan, et al.
Dermatology (Basel, Switzerland)|January 1, 1996
Effect of prophylactic benzathine penicillin on mucocutaneous symptoms of Behçet's diseaseM Calgüneri, I Ertenli, S Kiraz, et al.
Arthritis and Rheumatism|December 1, 1996
The effect of prophylactic penicillin treatment on the course of arthritis episodes in patients with Behçet's disease. A randomized clinical trialM Calgüneri, S Kiraz, I Ertenli, et al.
Clinical and Experimental Rheumatology|April 16, 2004
The contribution of underlying systemic rheumatic diseases to the mortality in patients admitted for intensive care: a matched cohort studyZ Ozbalkan, A Topeli, S Kiraz, et al.
Clinical and Experimental Rheumatology|November 2, 2004
The efficacy of continuous interferon alpha administration as an adjunctive agent to colchicine-resistant familial Mediterranean fever patientsM Calguneri, S Apras, Z Ozbalkan, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Annals of Internal Medicine|March 15, 1997
Treatment of Beçhet disease with pentoxifyllineM Arici, S Kiraz, I Ertenli
Clinical Nephrology|January 1, 1996
Increased prothrombin fragment 1.2 concentrations in hemodialysis patientsY Erdem, I C Haznedaroğlu, S Kiraz
Clinical and Experimental Rheumatology|January 1, 1996
Parvovirus B19 infection in Behçet's diseaseS Kiraz, I Ertenli, M Benekli, et al.
Annals of the Rheumatic Diseases|August 3, 2001
Parvovirus B19 infection in Behçet's diseaseS Kiraz, M A Oztürk, I Ertenli, et al.
Clinical Rheumatology|September 1, 1996
Antineutrophil cytoplasmic antibodies in systemic sclerosisS Kiraz, H Simsek, I Ertenli, et al.
Clinical and Experimental Rheumatology|April 22, 2010
Endothelial nitric oxide gene polymorphism and risk of systemic sclerosis: predisposition effect of T-786C promoter and protective effect of 27 bp repeats in Intron 4I Sinici, U Kalyoncu, S Karahan, et al.
Dermatology (Basel, Switzerland)|January 1, 1996
Effect of prophylactic benzathine penicillin on mucocutaneous symptoms of Behçet's diseaseM Calgüneri, I Ertenli, S Kiraz, et al.
Arthritis and Rheumatism|December 1, 1996
The effect of prophylactic penicillin treatment on the course of arthritis episodes in patients with Behçet's disease. A randomized clinical trialM Calgüneri, S Kiraz, I Ertenli, et al.
Clinical and Experimental Rheumatology|April 16, 2004
The contribution of underlying systemic rheumatic diseases to the mortality in patients admitted for intensive care: a matched cohort studyZ Ozbalkan, A Topeli, S Kiraz, et al.
Clinical and Experimental Rheumatology|November 2, 2004
The efficacy of continuous interferon alpha administration as an adjunctive agent to colchicine-resistant familial Mediterranean fever patientsM Calguneri, S Apras, Z Ozbalkan, et al.
Pageof 5